Cargando…
Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”
Autores principales: | Brocco, D., Lanuti, P., Simeone, P., Bologna, G., Pieragostino, D., Cufaro, M. C., Graziano, V., Peri, M., Di Marino, P., De Tursi, M., Grassadonia, A., Rapposelli, I. G., Pierdomenico, L., Ercolino, E., Ciccocioppo, F., Del Boccio, P., Marchisio, M., Natoli, C., Miscia, S., Tinari, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150712/ https://www.ncbi.nlm.nih.gov/pubmed/32318109 http://dx.doi.org/10.1155/2020/8947367 |
Ejemplares similares
-
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
por: Brocco, D., et al.
Publicado: (2019) -
Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019) -
Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors
por: Brocco, Davide, et al.
Publicado: (2021) -
Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers
por: Simeone, Pasquale, et al.
Publicado: (2020) -
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)